Procaps Group Investor Relations Material
Latest events
Investor Update
Procaps Group
Access the full event backlog
Slides, Transcripts, and Reports from 12,000+ public companies
Latest reports from Procaps Group S.A.
Access all reports
Procaps Group S.A. is a healthcare and pharmaceutical company that develops, manufactures, and markets a wide range of pharmaceutical solutions globally. The company's product offerings include branded prescription drugs across various therapeutic areas, over-the-counter (OTC) consumer healthcare products, and high-potency clinical compounds. Additionally, Procaps provides contract drug development and manufacturing services, specializing in soft gelatin capsule technologies. The company's operations are organized into several units, such as Diabetrics, which focuses on diabetes solutions, Farma Procaps, Softi Gel, Vital Care, and Clinical Specialties, each catering to specific healthcare needs. The company is headquartered in Luxembourg, and its shares are listed on the NASDAQ.
Latest articles
)
Moncler: From the Mountains to the Runway
The story of Moncler, all the way from its beginnings in the Alps to its journey to some of the most prestigious runways in the world.
16 Apr 2025
)
eToro: Innovation, Growth, and IPO Plans
eToro was founded in 2007 and has grown into a global trading platform with over 40 million users and an extensive offering across several asset classes.
10 Apr 2025
)
Yum! Brands: The Company Behind Pizza Hut, KFC, and Taco Bell
Yum! Brands started at PepsiCo in the 1970s and is home to some of the most well-known brands in the world, such as Pizza Hut, KFC, and Taco Bell.
9 Apr 2025
Ticker symbol
PROC
Country
🇺🇸 United States